Myriad Genetics (MYGN) Goodwill (2011 - 2026)

Myriad Genetics has disclosed Goodwill across 16 years of filings, most recently posting $47.1 million for Q1 2026.

• In Q1 2026, Goodwill fell 83.55% year-over-year to $47.1 million; the TTM figure through Mar 2026 stood at $47.1 million (down 83.55% YoY), while the FY2025 annual figure was $51.6 million, down 81.98% from the prior year.
• Goodwill fell to $47.1 million in Q1 2026, from $51.6 million in the prior quarter.
• Over the last five years, Goodwill for MYGN reached as high as $287.4 million in Q4 2023 and fell as low as $47.1 million in Q1 2026.
• The 5-year median for Goodwill is $286.3 million (2024), against an average of $222.5 million.
• Annual changes were most pronounced in 2023 — Goodwill climbed 21.18% — and 2026, when it slumped 83.55%.
• A 5-year view of Goodwill shows it stood at $286.8 million in 2022, then grew by 0.21% to $287.4 million in 2023, then dropped by 0.38% to $286.3 million in 2024, then slumped by 81.98% to $51.6 million in 2025, then slipped by 8.72% to $47.1 million in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $47.1 million, $51.6 million, and $51.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.